Literature DB >> 27018267

Current Strategy for Cisplatin Delivery.

Zhanguo Yue, Zhiqiang Cao1.   

Abstract

Cisplatin is one of the leading chemotherapy drugs currently used in clinical settings. However, its serious side effects and its resistance developed by tumor cells hinder its usage. To decrease its side effects and maintain anti-cancer efficiency, various cisplatin based formulations were developed. In this minireview, we summarized the recent progress of cisplatin delivery strategies, including direct delivery, prodrug delivery and combination delivery. Key challenges preventing the development of improved drug formulations were identified, and effective approaches to address these issues were discussed in the context of these recent works.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27018267     DOI: 10.2174/1568009616666160328113006

Source DB:  PubMed          Journal:  Curr Cancer Drug Targets        ISSN: 1568-0096            Impact factor:   3.428


  6 in total

1.  Chemosensitizing Effect of Astragalus Polysaccharides on Nasopharyngeal Carcinoma Cells by Inducing Apoptosis and Modulating Expression of Bax/Bcl-2 Ratio and Caspases.

Authors:  Zhen Zhou; Minhua Meng; Haifeng Ni
Journal:  Med Sci Monit       Date:  2017-01-26

2.  Synergistic Cytotoxicity of β-Elemene and Cisplatin in Gingival Squamous Cell Carcinoma by Inhibition of STAT3 Signaling Pathway.

Authors:  Chengyi Huang; Yufeng Yu
Journal:  Med Sci Monit       Date:  2017-03-29

3.  ATPase copper transporter A, negatively regulated by miR-148a-3p, contributes to cisplatin resistance in breast cancer cells.

Authors:  Ze Yu; Weifan Cao; Yuan Ren; Qijia Zhang; Jia Liu
Journal:  Clin Transl Med       Date:  2020-04-07

4.  DNA-affibody nanoparticle delivery system for cisplatin-based breast cancer chemotherapy.

Authors:  Chao Zhang; HongLei Zhang; MengNan Han; XueLi Yang; ChaoHong Pei; ZhiDong Xu; Jie Du; Wei Li; Shengxi Chen
Journal:  RSC Adv       Date:  2019-01-15       Impact factor: 4.036

5.  PEGylated Cisplatin Nanoparticles for Treating Colorectal Cancer in a pH-Responsive Manner.

Authors:  Wei Li; Yongjun Sun; Jian Chen; Zhibin Jiang; Jinbao Yang
Journal:  J Immunol Res       Date:  2022-08-05       Impact factor: 4.493

6.  The improved antitumor efficacy of continuous intratumoral chemotherapy with cisplatin-loaded implants for the treatment of sarcoma 180 tumor-bearing mice.

Authors:  Li Gao; Shang Cai; Awei Cai; Yang Zhao; Tangbing Xu; Yan Ma; Yan Xu; Yuan Wang; Hao Wang; Yong Hu
Journal:  Drug Deliv       Date:  2019-12       Impact factor: 6.419

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.